{"issuance_frequency":"","notes_translated":{"fr":"La Direction des produits thérapeutiques (DPT) de la Direction générale des produits de santé et des aliments (DGPSA) de Santé Canada procède à la révision du processus relatif aux exigences concernant les données probantes relatives aux bonnes pratiques de fabrication (BPF) pour les présentations de drogues. La révision vise à harmoniser davantage le processus d'évaluation et d'examen des présentations de drogue avec le processus d'obtention d'une LEPP, ce qui devrait permettre aux promoteurs de soumettre des présentations de drogues tout en assurant adéquatement l'engagement de l'établissement en faveur de la qualité.","en":"Evidence of Good Manufacturing Practices (GMP) for drug submissions. The goal of this revision is to better align the drug submission screening and review process with the Drug Establishment Licence (DEL) process. This should allow sponsors to make timely drug submissions while still providing adequate assurance of an establishment’s commitment to quality."},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"6ea2d390-3ee8-40e0-a534-91a700070dc5","metadata_created":"2021-07-07T16:31:28.816068","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2021-07-08T13:01:37.869440","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2021-07-07","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["présentation de drogue","exigences de dépôt de présentation","bonnes pratiques de fabrication","BPF","licences d'établissement de médicaments"],"en":["drug submission","submission filing requirements","good manufacturing practices","GMP","drug establishment licences"]},"relationships_as_object":[],"creator_user_id":"2dc5a12f-2a6f-4822-8514-165ea6bb05d9","title_translated":{"fr":"Avis : Exigences relatives au dépôt de présentations – Bonnes pratiques de fabrication (BPF) et licences d'établissement de produits pharmaceutiques (LEPP)","en":"Notice: Submission Filing Requirements - Good Manufacturing Practices (GMP)/Drug Establishment Licences (DEL)"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"6ea2d390-3ee8-40e0-a534-91a700070dc5","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"3d5ca2dd-7eb9-4225-b43a-ea6e7ceefabd","related_relationship":"","name_translated":{"fr":"Avis : Exigences relatives au dépôt de présentations – Bonnes pratiques de fabrication (BPF) et licences d'établissement de produits pharmaceutiques (LEPP)","en":"Notice: Submission Filing Requirements - Good Manufacturing Practices (GMP)/Drug Establishment Licences (DEL)"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Notice: Submission Filing Requirements - Good Manufacturing Practices (GMP)/Drug Establishment Licences (DEL)","language":["en"],"created":"2021-07-07T16:31:29.105200","url":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/notice-submission-filing-requirements-good-manufacturing-practices-establishment-licences.html","last_modified":null,"position":0,"revision_id":"b86f99c2-e5a8-4c31-9e37-f8fae42ac128","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6ea2d390-3ee8-40e0-a534-91a700070dc5","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"004188b1-dee2-46e0-be77-a3aa13032b3d","related_relationship":"","name_translated":{"fr":"Avis : Exigences relatives au dépôt de présentations – Bonnes pratiques de fabrication (BPF) et licences d'établissement de produits pharmaceutiques (LEPP)","en":"Notice: Submission Filing Requirements - Good Manufacturing Practices (GMP)/Drug Establishment Licences (DEL)"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Notice: Submission Filing Requirements - Good Manufacturing Practices (GMP)/Drug Establishment Licences (DEL)","language":["fr"],"created":"2021-07-07T16:31:29.105206","url":"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/demandes-presentations/lignes-directrices/avis-exigences-relatives-depot-presentations-bonnes-pratiques-fabrication-licence-etablissement-avis.html","last_modified":null,"position":1,"revision_id":"b86f99c2-e5a8-4c31-9e37-f8fae42ac128","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Santé Canada","en":"Health Canada"},"date_published":"2017-02-10 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:33.001625","title":"Health Canada | Santé Canada","name":"hc-sc","is_organization":true,"state":"active","image_url":"","revision_id":"6a0471e8-36e5-4217-8f72-563c83e6465a","type":"organization","id":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","approval_status":"approved"},"name":"6ea2d390-3ee8-40e0-a534-91a700070dc5","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"Evidence of Good Manufacturing Practices (GMP) for drug submissions. The goal of this revision is to better align the drug submission screening and review process with the Drug Establishment Licence (DEL) process. This should allow sponsors to make timely drug submissions while still providing adequate assurance of an establishment’s commitment to quality.","owner_org":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Notice: Submission Filing Requirements - Good Manufacturing Practices (GMP)/Drug Establishment Licences (DEL)","revision_id":"210bb28b-0a1d-416b-bc48-ae4153681d64"}